Cooper C. Collins, Chief Strategic Officer at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 90,000 shares at $5.28 ($473K) on 2014-04-01, disclosed to the SEC on 2014-04-02.
Scheduled sale ($473k) by Chief Strategic Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.28 | 66,102 | $349K | 73.8% |
| 2 | $5.19 | 23,898 | $124K | 26.2% |
| Total | $5.26 avg | 90,000 | $473K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |